Extracellular matrix, nuclear and chromatin structure, and gene expression in normal tissues and malignant tumors: a work in progress.
Almost three decades ago, we presented a model where the extracellular matrix (ECM) was postulated to influence gene expression and tissue-specificity through the action of ECM receptors and the cytoskeleton. This hypothesis implied that ECM molecules could signal to the nucleus and that the unit of function in higher organisms was not the cell alone, but the cell plus its microenvironment. We now know that ECM invokes changes in tissue and organ architecture and that tissue, cell, nuclear, and chromatin structure are changed profoundly as a result of and during malignant progression. Whereas some evidence has been generated for a link between ECM-induced alterations in tissue architecture and changes in both nuclear and chromatin organization, the manner by which these changes actively induce or repress gene expression in normal and malignant cells is a topic in need of further attention. Here, we will discuss some key findings that may provide insights into mechanisms through which ECM could influence gene transcription and how tumor cells acquire the ability to overcome these levels of control.
Spencer
Virginia A
VA
Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA.
Xu
Ren
R
Bissell
Mina J
MJ
D000818:Animals; D001943:Breast Neoplasms / Q000235:genetics / Q000473:pathology; D002467:Cell Nucleus / Q000502:physiology* / Q000648:ultrastructure; D002843:Chromatin / Q000502:physiology* / Q000648:ultrastructure; D004273:DNA, Neoplasm / Q000235:genetics; D005109:Extracellular Matrix / Q000502:physiology* / Q000648:ultrastructure; D016326:Extracellular Matrix Proteins / Q000502:physiology; D005260:Female; D005786:Gene Expression Regulation; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008325:Mammary Neoplasms, Experimental / Q000235:genetics / Q000473:pathology; D051379:Mice; D008954:Models, Biological; D009024:Morphogenesis; D009363:Neoplasm Proteins / Q000502:physiology; D009687:Nuclear Proteins / Q000502:physiology; D011388:Prolactin / Q000494:pharmacology; D021381:Protein Transport; D020218:Response Elements / Q000235:genetics; D046509:Tissue Culture Techniques / Q000295:instrumentation / Q000379:methods; D014158:Transcription, Genetic
D002843:Chromatin; D004273:DNA, Neoplasm; D016326:Extracellular Matrix Proteins; D009363:Neoplasm Proteins; D009687:Nuclear Proteins; D011388:Prolactin